LASSO-derived model for the prediction of lean-non-alcoholic fatty liver disease in examinees attending a routine health check-up

References

• Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):1–10. doi: 10.1002/hep.28431.
   PubMed Web of Science ®Google Scholar
• Allen AM, Therneau TM, Larson JJ, et al. Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: a 20 year-community study. Hepatology. 2018;67(5):1726–1736. doi: 10.1002/hep.29546.
   PubMed Web of Science ®Google Scholar
• Shi Y, Wang Q, Sun Y, et al. The prevalence of lean/nonobese nonalcoholic fatty liver disease: a systematic review and meta-analysis. J Clin Gastroenterol. 2020;54(4):378–387. doi: 10.1097/MCG.0000000000001270.
   PubMed Web of Science ®Google Scholar
• Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11–20. doi: 10.1038/nrgastro.2017.109.
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Henry L. Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma. JHEP Rep. 2021;3(4):100305. doi: 10.1016/j.jhepr.2021.100305.
   PubMedGoogle Scholar
• Cruz ACD, Bugianesi E, George J, et al. 379 Characteristics and long-term prognosis of lean patients with nonalcoholic fatty liver disease. Gastroenterology. 2014;146(5):S-909. doi: 10.1016/S0016-5085(14)63307-2.
   Web of Science ®Google Scholar
• Feldman A, Wernly B, Strebinger G, et al. Liver-related mortality is increased in lean subjects with non- alcoholic fatty liver disease compared to overweight and obese subjects. J Gastrointestin Liver Dis. 2021;30(3):366–373. doi: 10.15403/jgld-3622.
   PubMed Web of Science ®Google Scholar
• Zou B, Yeo YH, Nguyen VH, et al. Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016. J Intern Med. 2020;288(1):139–151. doi: 10.1111/joim.13069.
   PubMed Web of Science ®Google Scholar
• Nabi O, Lapidus N, Boursier J, et al. Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO study). Hepatology. 2023;78(1):272–283. doi: 10.1097/HEP.0000000000000329.
   PubMed Web of Science ®Google Scholar
• Castellana M, Donghia R, Guerra V, et al. Performance of fatty liver index in identifying non-alcoholic fatty ­liver disease in population studies. A meta-analysis. J Clin Med. 2021;10(9):1877.
   PubMed Web of Science ®Google Scholar
• Chen L-W, Huang P-R, Chien C-H, et al. A community-based study on the application of fatty liver index in screening subjects with nonalcoholic fatty liver disease. J Formos Med Assoc. 2020;119(1 Pt 1):173–181. doi: 10.1016/j.jfma.2019.03.016.
   PubMed Web of Science ®Google Scholar
• Cuthbertson DJ, Koskinen J, Brown E, et al. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD). Ann Med. 2021;53(1):1256–1264.
   PubMed Web of Science ®Google Scholar
• Motamed N, Faraji AH, Khonsari MR, et al. Fatty liver index (FLI) and prediction of new cases of non-alcoholic fatty liver disease: a population-based study of Northern Iran. Clin Nutr. 2020;39(2):468–474. doi: 10.1016/j.clnu.2019.02.024.
   PubMed Web of Science ®Google Scholar
• Hsu CL, Wu FZ, Lin KH, et al. Role of fatty liver index and metabolic factors in the prediction of nonalcoholic fatty liver disease in a lean population receiving health checkup. Clin Transl Gastroenterol. 2019;10(5):1–8. doi: 10.14309/ctg.0000000000000042.
   PubMedGoogle Scholar
• DiStefano JK, Gerhard GS. Metabolic dysfunction and nonalcoholic fatty liver disease risk in individuals with a normal body mass index. Curr Opin Gastroenterol. 2023;39(3):156–162. doi: 10.1097/MOG.0000000000000920.
   PubMed Web of Science ®Google Scholar
• Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13(3):275–286. doi: 10.1111/j.1467-789X.2011.00952.x.
   PubMed Web of Science ®Google Scholar
• Pimenta NM, Santa-Clara H, Melo X, et al. Waist-to-hip ratio is related to body fat content and distribution regardless of the waist circumference measurement protocol in nonalcoholic fatty liver disease patients. Int J Sport Nutr Exerc Metab. 2016;26(4):307–314. doi: 10.1123/ijsnem.2014-0256.
   PubMed Web of Science ®Google Scholar
• Zheng RD, Chen ZR, Chen JN, et al. Role of body mass index, waist-to-height and waist-to-hip ratio in prediction of nonalcoholic fatty liver disease. Gastroenterol Res Pract. 2012;2012:1–6. doi: 10.1155/2012/362147.
   Web of Science ®Google Scholar
• Cai J, Lin C, Lai S, et al. Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western chinese male population. Lipids Health Dis. 2021;20(1):145. doi: 10.1186/s12944-021-01568-9.
   PubMed Web of Science ®Google Scholar
• Lin MS, Lin TH, Guo SE, et al. Waist-to-height ratio is a useful index for nonalcoholic fatty liver disease in children and adolescents: a secondary data analysis. BMC Public Health. 2017;17(1):851. doi: 10.1186/s12889-017-4868-5.
   PubMedGoogle Scholar
• Hyattsville M. 2022. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. U.S.: Department of Health and Human Services, Centers for Disease Control and Prevention; [cited 2022 Nov 14]. https://www.cdc.gov/alcohol/fact-sheets/binge-drinking.htm.
   Google Scholar
• Bedogni G, Bellentani S, Miglioli L, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6(1):33. doi: 10.1186/1471-230X-6-33.
   PubMed Web of Science ®Google Scholar
• Yang BL, Wu WC, Fang KC, et al. External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan. PLOS One. 2015;10(3):e0120443. doi: 10.1371/journal.pone.0120443.
   PubMed Web of Science ®Google Scholar
• Huang TD, Behary J, Zekry A. Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management. Intern Med J. 2020;50(9):1038–1047. doi: 10.1111/imj.14709.
   PubMed Web of Science ®Google Scholar
• Machado MV, Cortez-Pinto H. Management of fatty liver disease with the metabolic syndrome. Expert Rev Gastroenterol Hepatol. 2014;8(5):487–500. doi: 10.1586/17474124.2014.903798.
   PubMed Web of Science ®Google Scholar
• Souza M, Diniz M, Medeiros-Filho J, et al. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arq Gastroenterol. 2012;49(1):89–96. doi: 10.1590/s0004-28032012000100015.
   PubMedGoogle Scholar
• Saad RK, Ghezzawi M, Horanieh R, et al. Abdominal visceral adipose tissue and all-cause mortality: a systematic review. Front Endocrinol. 2022;13:922931. doi: 10.3389/fendo.2022.922931.
   PubMed Web of Science ®Google Scholar
• Kwon YM, Oh SW, Hwang SS, et al. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in korean adults. Am J Gastroenterol. 2012;107(12):1852–1858. doi: 10.1038/ajg.2012.314.
   PubMed Web of Science ®Google Scholar
• Mirza MS. Obesity, visceral fat, and NAFLD: querying the role of adipokines in the progression of nonalcoholic fatty liver disease. ISRN Gastroenterol. 2011;2011:592404–592411. doi: 10.5402/2011/592404.
   PubMedGoogle Scholar
• Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158(7):1851–1864. doi: 10.1053/j.gastro.2020.01.052.
   PubMed Web of Science ®Google Scholar
• Kim D, Chung GE, Kwak MS, et al. Body fat distribution and risk of incident and regressed nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2016;14(1):132–138.e4. e134. doi: 10.1016/j.cgh.2015.07.024.
   PubMed Web of Science ®Google Scholar
• Guilherme A, Virbasius JV, Puri V, et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9(5):367–377. doi: 10.1038/nrm2391.
   PubMed Web of Science ®Google Scholar
• Nielsen S, Guo Z, Johnson CM, et al. Splanchnic lipolysis in human obesity. J Clin Invest. 2004;113(11):1582–1588. doi: 10.1172/JCI200421047.
   PubMed Web of Science ®Google Scholar
• Muzurović E, Mikhailidis DP, Mantzoros C. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism. 2021;119:154770. doi: 10.1016/j.metabol.2021.154770.
   PubMed Web of Science ®Google Scholar
• Peng K, Mo Z, Tian G. Serum lipid abnormalities and nonalcoholic fatty liver disease in adult males. Am J Med Sci. 2017;353(3):236–241. doi: 10.1016/j.amjms.2017.01.002.
   PubMed Web of Science ®Google Scholar
• Hu H, Han Y, Liu Y, et al. Triglyceride: a mediator of the association between waist-to-height ratio and non-alcoholic fatty liver disease: a second analysis of a population-based study. Front Endocrinol. 2022;13:973823. doi: 10.3389/fendo.2022.973823.
   PubMed Web of Science ®Google Scholar
• Arguello G, Balboa E, Arrese M, et al. Recent insights on the role of cholesterol in non-alcoholic fatty liver disease. Biochim Biophys Acta. 2015;1852(9):1765–1778. doi: 10.1016/j.bbadis.2015.05.015.
   PubMed Web of Science ®Google Scholar
• Cen C, Wang W, Yu S, et al. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease. Hepatol Int. 2020;14(5):808–816. doi: 10.1007/s12072-020-10065-7.
   PubMed Web of Science ®Google Scholar
• Su PY, Chen YY, Lin CY, et al. Comparison of machine learning models and the fatty liver index in predicting lean fatty liver. Diagnostics. 2023;13(8):1407. doi: 10.3390/diagnostics13081407.
   Web of Science ®Google Scholar
• Liu L, Shi X, Gao J, et al. Predictive risk factors of nonalcoholic fatty liver disease in a lean Chinese population. J Pers Med. 2022;12(12):1958.
   PubMed Web of Science ®Google Scholar
• Wang J, Tang Y, Peng K, et al. Development and validation of a nomogram for predicting nonalcoholic fatty liver disease in the non-obese Chinese population. Am J Transl Res. 2020;12(10):6149–6159.
   PubMed Web of Science ®Google Scholar